FolioLanternBeta
CORTCorcept Therapeutics Inc

David Mahoney

Director at Corcept Therapeutics Inc, as of Aug 20, 2026Sold $12.3M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
1.13M
shares held after the latest filing, Corcept Therapeutics Inc
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
104K
shares sold, past 12 months
1
days with sales
$12.3M
largest single day, Aug 18, 2026
2
companies filed for

Share of stake sold at Corcept Therapeutics Inc is not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJunJulAug 2026: $12.3M under a disclosed plan$12.3MAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Corcept Therapeutics Inc (CORT)DirectorJul 22, 2004Aug 20, 2026
Gen Digital (GEN)Former DirectorNov 25, 2003May 17, 2019

Also a director at

Gen Digital (GEN) (no filing in the last 18 months)

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.